Is Shield Technology publicly traded?

**Bottom line 🛡️:**
No – Shield AI (sometimes informally called “Shield Technology”) is **still a privately held company and does not trade on any public stock exchange** .

---

### What we know so far
| Aspect | Details |
|--------|---------|
| Corporate status | Privately held startup, founded in 2015 |
| Latest funding | March 2025, Series E≈ $240 million, investors include L3 Harris & Andreessen Horowitz |
| Valuation | Estimated above **$5 billion** after recent rounds |
| Core products | Hivemind AI pilot software; V-BAT drone (fielded), new X-BAT VTOL “wingman” fighter concept |
| IPO plans | No public filings or announced timeline as of Oct 2025 |

Because Shield AI remains private, shares are not available via regular brokerage accounts. Access is generally limited to venture-capital rounds or private secondary markets, often restricted to accredited investors.

### Ways public-market investors can still play the theme
1. **Partner & Investor Exposure**
• L3Harris Technologies (LHX) – Strategic investor in Shield AI .
• Pratt & Whitney (RTX) & General Electric (GE) – Supplying engines for X-BAT .
• Anduril (private) & Kratos Defense (KTOS) – Peer “loyal wingman” drone developers.

2. **Defense & Aerospace ETFs**
• Tickers such as ITA or PPA provide broad exposure to U.S. defense primes—an option for diversified, mid-term positioning aligned with your existing interest in Aerospace & Defense.

3. **Private-Market Access**
• Platforms like Forge or EquityZen sometimes list secondary shares of late-stage startups (accredited-investor only). Liquidity and pricing can be opaque, and allocations limited.

### What’s next?
Shield AI’s roadmap targets first VTOL flights for X-BAT in 2026 and “full mission capability” by 2028 . An IPO could follow successful prototype milestones or major Pentagon contracts, but timing is speculative.

---

🤔 **Your move**
Given your beyond-aggressive risk tolerance and interest in frontier defense tech, would you like to explore:
• Building indirect exposure via publicly traded partners/ETFs?
• Keeping tabs on secondary-market opportunities for private shares?
• Or delving deeper into comparable public companies in the autonomous defense space? Let me know which avenue excites you most, and we’ll chart the next steps together!